Form 4 · Filed Jun 6, 2026, 12:00 AM UTC
APGE/Apogee Therapeutics, Inc.
Dambkowski Carl — Chief Medical Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | M | other | 4,125 | $23 | $94,298 | 211,148 |
| Jun 3, 2026 | S | sell | 5,500 | $79 | $432,905 | 205,648 |
| Jun 3, 2026 | M | other | 4,125 | — | — | 118,915 |
Source: SEC EDGAR raw filing ↗ · Accession 0001104659-26-071076